Johanna Ivaska | |
---|---|
Born | 1972 (age 50–51) |
Nationality | Finnish |
Parent | Ari Ivaska |
Academic background | |
Alma mater | University of Turku |
Academic work | |
Discipline | Molecular cell biology |
Sub-discipline | Cancer research |
Institutions | University of Turku VTT Technical Research Centre of Finland |
Website | www |
Mari Johanna Ivaska (born 1972) is a cancer researcher and molecular cell biology academy professor in University of Turku,Finland. [1]
Johanna Ivaska was born 1972 in Turku,Finland. [2] Her father is emeritus analytical chemistry professor Ari Ivaska. [3] She did her master's studies in University of Turku. Her PhD on collagen-binding integrins in University of Turku was give an honorary mention for an excellent PhD thesis by the Faculty of Medicine,University of Turku in 2001. [4] After receiving a PhD she moved to London,UK for a postdoctoral work on investigating how integrins and protein kinases work together in cancer migration at Cancer Research UK with professor Peter J. Parker. [1]
Ivaska established her lab in 2003 at VTT Technical Research Centre of Finland. [1] Currently Ivaska Lab is situated in Turku Centre for Biotechnology. [5] Ivaska's research concentrates on cell surface receptors called integrins and how these affect to cancer cell migration,invasion,tumour-stroma crosstalk and other processes that promote cancer progression. Research aims to find novel regulators for integrin activity,understanding the integrin traffic,and link between integrin activity regulation and mechanosensing. The group also does research on cellular machinery that facilitates cancer cell migration. In this,filopodia are important. Ivaska's group has discovered unconventional myosin that regulates filopodia formation,possibly providing a potential cancer therapeutic. [1] [5]
She is married to immunology professor Marko Salmi and they have twin girls (born 2005). [2] Her hobbies include marathon running that she also does for charity,boating and outdoor life in the Archipelago Sea. [2] [3]
Cell division control protein 42 homolog,also known as Cdc42,is a protein involved in regulation of the cell cycle. It was originally identified in S. cerevisiae (yeast) as a mediator of cell division,and is now known to influence a variety of signaling events and cellular processes in a variety of organisms from yeast to mammals.
Myosin X,also known as MYO10,is a protein that in humans is encoded by the MYO10 gene.
Carlos Martínez Alonso, was born in Villasimpliz,in the province of León,on January 9,1950. In 1974 he obtained a chemistry degree from the Universidad Complutense of Madrid. Four years later,in 1978,he obtained a Ph.D. in immunology by the same university. He was appointed President of the Spanish National Research Council (CSIC) from 2004 to 2008,and Secretary of State for Research in the Ministry of Science and Innovation from early 2008 to December 2009.
The Eino Leino Prize is an annual prize award to top writers in Finland since 1956,with particular emphasis on poets.
Ivan Đikić is a Croatian-German molecular biologist who is the Director of the Institute of Biochemistry II at Goethe University Frankfurt.
Carl-Henrik Heldin is Chairman of the Board for the Nobel Foundation,and a molecular biologist and medical researcher. He has been director of the Uppsala branch of Ludwig Cancer Research since 1986 and professor in molecular cell biology at the medical faculty of Uppsala University since 1992. He is vice-president of the European Research Council since 2011 and was appointed chairman of the Nobel Foundation in 2013.
Michael Nip Hall is an American-Swiss molecular biologist and professor at the Biozentrum University of Basel,Switzerland.
Michael Jeltsch is a German-Finnish researcher in the field of Biochemistry. He is an associate professor at the University of Helsinki,Finland. He has more than 70 publications. Jeltsch was the first to show that VEGF-C and VEGF-D are the principal growth factors for the lymphatic vasculature and his research focuses on cancer drug targets and lymphangiogenesis. He has also contributed to other seminal publications in cell biology with transgenesis,protein engineering,recombinant production and purification. In 2006,he developed a synthetic super-VEGF,using a library of VEGF hybrid molecules using a novel,non-random DNA family shuffling method.
Nektarios N. Tavernarakis is a bioscientist,who studies Ageing,Cell death,and Neurodegeneration. He is currently Professor of Molecular Systems Biology at the Medical School of the University of Crete,and the Chairman of the Board of Directors at the Foundation for Research and Technology,in Heraklion,Crete,Greece. He is also the founder and first Director of the Graduate Program in Bioinformatics of the University of Crete Medical School,and has served as Director of the Institute of Molecular Biology and Biotechnology,where he is heading the Neurogenetics and Ageing laboratory. He was elected Vice President of the European Research Council (ERC) in 2020,and Chairman of the European Institute of Innovation and Technology (EIT) Governing Board and Executive Committee in 2022.
Andrea Ablasser is a German immunologist,who works as a full professor of Life Sciences at the École Polytechnique Fédérale de Lausanne. Her research has focused on how the innate immune system is able to recognise virus-infected cells and pathogens.
Daniel Louvard is a French scientist with the Department of Cell Biology in the Curie institute,Paris. In 1996 he won the Richard Lounsbery Award jointly with Jacques Pouysségur for "their contributions to the study of the regulation of cell division and differentiation."
Erwin Friedrich Wagner is an Austrian biochemist known for his research on the molecular basis of cancer and associated conditions such as inflammation and cachexia. He was Deputy Director of the Spanish National Cancer Research Center (CNIO) in Madrid,Spain until 2019. Since 2019,Wagner is a group leader affiliated with the Medical University of Vienna.
Jan O. Korbel is a German scientist working in the fields of Human Genetics,Genomics and Computational Biology. He is a tenured principal investigator and Head of Data Science at the European Molecular Biology Laboratory Heidelberg,Germany,senior scientist in the Genome Biology Unit,is leading a bridging research division at the German Cancer Research Center (DKFZ),and is an honorary professor ("Honorarprofessor") at Heidelberg University. A particular focus of the Korbel group is on investigating a particular form of mutation,genomic structural variation,which includes deletions,inversions and more complex chromosomal rearrangements such as chromothripsis events that can occur in healthy individuals and in context of disease. His group's principal research objective is to understand genomic structural variations as a basis of phenotypic variation and cancer development.
Marileen Dogterom is a Dutch biophysicist and professor at the Kavli Institute of Nanoscience at Delft University of Technology. She published in Science,Cell,and Nature and is notable for her research of the cell cytoskeleton. For this research,she was awarded the 2018 Spinoza Prize.
Victoria Haigh Cowling FRSE is an English biologist who received the Women in Cell Biology Early Career Medal from the British Society for Cell Biology in 2014. Cowling is Professor of Biology,Lister Institute Fellow,MRC Senior Fellow and Deputy Head of The Centre for Gene Regulation and Expression at the University of Dundee.
Kairbaan Hodivala-Dilke, FMedSci is an English cell biologist who has made significant contributions to the understanding of the cellular and molecular biology of the tumour microenvironment and in particular angiogenesis. She is Professor of Angiogenesis and the Tumour Microenvironment and Deputy Institute Director of Barts Cancer Institute,Queen Mary University of London. In 2015 she was awarded the Hooke medal from the British Society for Cell Biology and EMBO membership.
Leena Maria Ala-Kokko is a Finnish biochemist and molecular biologist,whose research concerns collagens,in particular those found in cartilage,as well as connective tissue disease. She has worked as a professor both in Finland and in the United States and,with her husband,runs a US-based company that carries out molecular diagnostic testing of connective tissue diseases.
Dirk Schübeler is a German researcher,Director of the Friedrich Miescher Institute for Biomedical Research (FMI) and professor at the University of Basel. He is an expert in gene regulation.
Reuven Agami is a Dutch cancer researcher. He is a professor of Oncogenomics at Erasmus University Rotterdam and head of the section of Oncogenomics at the Netherlands Cancer Institute-Antoni van Leeuwenhoekziekenhuis.
Edna "Eti" Cukierman is a Mexican biochemist who is a professor at the Fox Chase Cancer Center. She serves as co-director of the Marvin &Concetta Greenberg Pancreatic Cancer Institute. Her research investigates pancreatic cancer and the tumor microenvironment.